Ljubljana, Slovenia

Bostjan Markun

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2019.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bostjan Markun: Innovator in Pharmaceutical Composition

Introduction

Bostjan Markun is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of compositions that include poorly soluble active ingredients. His work is essential for advancing treatments for various health conditions.

Latest Patents

Markun holds a patent for a process that prepares a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient. This innovative composition is designed to generate a dosage form that effectively treats hypercholesterolemia. His patent is a testament to his commitment to improving pharmaceutical formulations and patient outcomes.

Career Highlights

Bostjan Markun is associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. His role at Lek Pharmaceuticals allows him to apply his expertise in developing effective pharmaceutical solutions. His contributions have been instrumental in enhancing the company's product offerings.

Collaborations

Markun collaborates with talented professionals in his field, including Rok Staric and Simon Skubin. These partnerships foster innovation and drive advancements in pharmaceutical research and development.

Conclusion

Bostjan Markun's work in pharmaceutical compositions highlights his dedication to improving healthcare solutions. His innovative approach and collaboration with industry professionals continue to make a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…